Related Articles
Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review
Sunitinib in patients with metastatic renal cell carcinoma: Birmingham experience
Docetaxel plus epirubicin as first-line chemotherapy in MBC (KCSG 01-10-05): Phase II trial and the predictive values of circulating HER2 extracellular domain and vascular endothelial growth factor
A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma